Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression. (Q42149153)
Jump to navigation
Jump to search
scientific article published on 18 July 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression. |
scientific article published on 18 July 2012 |
Statements
Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression (English)
S Bomken
L Buechler
K Rehe
F Ponthan
A Elder
H Blair
1 reference
1 reference